Gene · 8862
Papers4,102
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 4,102
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Determination of the relationship between thymoquinone and apelin in isoproterenol-induced myocardial infarction. | Tissue Cell | 2026 | 42229283 | PubTator, text mining | PubMed |
| Role of Apelin in Type II Diabetes Mellitus. | Cureus | 2026 | 42211608 | PubTator, text mining | PubMed |
| Key cellular subpopulations and mechanisms of propranolol in infantile hemangioma: insights from single-cell omics. | Front Med (Lausanne) | 2026 | 42210920 | PubTator, text mining | PubMed |
| Reduced plasma APJ levels and APLNR G212A polymorphism in Syrian patients with coronary artery disease. | Curr Med Res Opin | 2026 | 42207182 | PubTator, text mining | PubMed |
| Discriminative Ability and Clinical Associations of Serum SIRT1, SIRT3, Apelin, and ELA in Patients with Diabetic Foot Infection. | Life (Basel) | 2026 | 42195360 | PubTator, text mining | PubMed |
| Exercise-Induced Myokines in Obesity-Related Metabolic Disorders and Cardiovascular Protection: A Narrative Review. | Sports (Basel) | 2026 | 42188588 | PubTator, text mining | PubMed |
| Adipokines in oral squamous cell carcinoma-a narrative overview. | BDJ Open | 2026 | 42135288 | PubTator, text mining | PubMed |
| Do apelin and ghrelin play a role in multiple sclerosis? The analysis of patients treated with immunomodulatory therapies. | Front Immunol | 2026 | 42131351 | PubTator, text mining | PubMed |
| Integrative bioinformatic analysis prioritizes TIMP1 and FN1 as angiogenesis-related candidate genes in diabetic foot ulcers. | PLoS One | 2026 | 42127081 | PubTator, text mining | PubMed |
| Placental apelin expression is low in early-onset fetal growth restriction but there is no association between maternal circulating apelin and pregnancy outcome. | Placenta | 2026 | 42061341 | PubTator, text mining | PubMed |
| Cardiomyocyte-Derived Apelin Rescues Viral Myocarditis-Induced Cardiac Lymphatic Dysfunction and Remodeling. | JACC Basic Transl Sci | 2026 | 42048852 | PubTator, text mining | PubMed |
| Cardioprotective Effect of Apelin and Apela: The Receptor and Signaling Mechanism. | Curr Rev Clin Exp Pharmacol | 2026 | 42003195 | PubTator, text mining | PubMed |
| Targeting the Apelin-APJ Axis: A Promising Strategy to Mitigate Anthracycline-Induced Cardiotoxicity. | Cardiovasc Toxicol | 2026 | 41995966 | PubTator, text mining | PubMed |
| Empagliflozin improves metabolism and prevents myocardial and coronary dysfunction in streptozotocin-diabetic and non-diabetic rats subjected to ischemia/reperfusion. | Basic Res Cardiol | 2026 | 41995817 | PubTator, text mining | PubMed |
| Context‑dependent duality of the apelin/elabela‑APJ system in diabetes and its complications (Review). | Int J Mol Med | 2026 | 41992965 | PubTator, text mining | PubMed |
| A Novel Marker in Hypogonadal Hypogonadism: Apelin. | Sisli Etfal Hastan Tip Bul | 2026 | 41988064 | PubTator, text mining | PubMed |
| Salivary Apelin and Asprosin Levels in Periodontitis and Diabetes Mellitus and Their Relationship with Clinical Periodontal Parameters. | Diagnostics (Basel) | 2026 | 41975764 | PubTator, text mining | PubMed |
| Clinicopathological Study of Placentae of Twin Pregnancies with Emphasis on Exploration of Expression of Two Novel Markers, Annexin A5 and Apelin. | Turk Patoloji Derg | 2026 | 41968879 | PubTator, text mining | PubMed |
| A bioengineered recombinant spider silk provides targeted G-protein-coupled receptor activation. | Acta Biomater | 2026 | 41933774 | PubTator, text mining | PubMed |
| Suppressed brain-derived neurotrophic factor response to 6 min walking exercise in mild cognitive impairment. | Brain Behav Immun | 2026 | 41912101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8862/papers?page=3